Predictors of aggressive response towards simulated intruders depend on context and sex in Crimson Finches (Neochmia phaeton).

Behav Processes

The Australian National University, Division of Ecology, Evolution and Genetic, Research School of Biology, Building 44 Daley Road, Acton, Canberra, ACT 2601, Australia. Electronic address:

Published: May 2017

Quantifying differences in aggressive behaviour across contexts can be useful in developing an understanding of life histories and breeding systems, as well as the relative costs and benefits of such behaviour. We investigated whether age, relative body size and colouration, sex, and breeding stage influenced levels of aggressive behaviour in two contexts, towards conspecific and heterospecific intruders (mounts) around active nests of group living Crimson Finches (Neochmia phaeton). We found that when responding to a conspecific mount, relative body size, and age were important in predicting the aggressive response of males toward a conspecific, with older males and those close in size to their opponent showing a higher aggressive response. On the other hand, factors relating to female aggression were not as clear. In contrast, response to a heterospecific mount was unrelated to age, colour or size in either sex. Additionally, although birds were equally aggressive to conspecific and heterospecific mount types, we found no evidence that individuals are consistent in their level of aggression across these contexts. This suggests that aggressive behaviour in Crimson Finches is at least partially plastic and that individuals may be capable of assessing and responding to situations independently.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beproc.2017.01.017DOI Listing

Publication Analysis

Top Keywords

aggressive response
12
crimson finches
12
aggressive behaviour
12
finches neochmia
8
neochmia phaeton
8
behaviour contexts
8
relative body
8
body size
8
conspecific heterospecific
8
heterospecific mount
8

Similar Publications

Rare cancers present significant challenges in diagnosis, treatment, and research, accounting for up to 25% of global cancer cases. Due to their rarity and atypical presentations, they are often misdiagnosed, resulting in late-stage detection and poor outcomes. Here, we describe a patient case with advanced metastatic nasopharynx NUT carcinoma, one of the rarest and most aggressive cancers.

View Article and Find Full Text PDF

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment.

Cell Death Dis

January 2025

Department of Organ Transplantation and Hepatobiliary Surgery, Key Laboratory of Organ Transplantation of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.

TSC2, a suppressor of mTOR, is inactivated in up to 20% of HBV-associated liver cancer. This subtype of liver cancer is associated with aggressive behavior and early recurrence after hepatectomy. Being the first targeted regimen for advanced liver cancer, sorafenib has limited efficacy in HBV-positive patients.

View Article and Find Full Text PDF

Chronic lymphocytic leukemia is a malignant lymphoproliferative disorder for which primary or acquired drug resistance represents a major challenge. To investigate the underlying molecular mechanisms, we generate a mouse model of ibrutinib resistance, in which, after initial treatment response, relapse under therapy occurrs with an aggressive outgrowth of malignant cells, resembling observations in patients. A comparative analysis of exome, transcriptome and proteome of sorted leukemic murine cells during treatment and after relapse suggests alterations in the proteasome activity as a driver of ibrutinib resistance.

View Article and Find Full Text PDF

To investigate the clinicopathological and genetic features of infantile rhabdomyofibrosarcoma (IRFS) with EGFR kinase domain duplication (EGFR-KDD). The clinical, morphological and immunohistochemical features of three IRFS with EGFR-KDD diagnosed from January 2022 to January 2024 at Department of Pathology, Foshan Traditional Chinese Medicine Hospital, Foshan, China were retrospectively analyzed using PCR or next generation sequencing technique; and related literature was reviewed. There were 1 male and 2 females, aged at presentation ranging from 1 to 4 years.

View Article and Find Full Text PDF

Associations of Serum Urate and Cardiovascular Events in a Clinical Trial of Interleukin-1β Blockade.

JACC Adv

January 2025

Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and Cardiovascular Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Background: Serum urate (SU) associates with cardiovascular (CV) events, mortality, and gout.

Objectives: The purpose of this study was to assess whether SU predicts CV risk in a trial of interleukin (IL)-1β inhibition with canakinumab, and whether IL-1β blockade, kidney function, or gout alter these associations.

Methods: This study is a subanalysis of the Canakinumab Antiinflammatory Thrombosis Outcome Study (CANTOS), which randomized 10,061 patients with prior myocardial infarction and elevated high-sensitivity C-reactive protein to 3 doses of canakinumab or placebo.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!